Author: Dr. David Lowemann

Ketamine Use Is on the Rise in US

Many more Americans are turning to ketamine for kicks, a new study reports. Recreational use of the anesthetic drug among U.S. adults increased 40% between 2021 and 2022, researchers say. That follows a nearly 82% increase in ketamine use from 2015 to 2019, results show. The… Read Full Article (External Site) Dr. David LowemannDr. David […]

Published on January 20, 2025

Report Reveals High Lead Levels in Protein Powders

It turns out, your protein powder might not be as healthy as you think. A new report from the Clean Label Project reveals that popular protein powders – especially plant-based, organic and chocolate-flavored varieties – may contain high levels of lead and cadmium. The report… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, […]

Published on January 20, 2025

Impact of Medicare Price Negotiation of Wegovy

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk’s blockbuster weight-loss drug Wegovy. Here’s what Wall Street analysts say about the inclusion: WHAT IT MEANS FOR… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder […]

Published on January 20, 2025